Medical Devices – CrispIdea

Medical Devices

All
Healthcare
Life Sciences
Medical Devices

March 3, 2021

Abbott Laboratories (ABT) – Rapid antigen test BinaxNOW for Covid 19 will boost revenue for next year

Abbott Laboratories achieved a number of product approvals which include the approval of MitraClip G4, the latest generation of market leading system to repair a leaky mitral heart valve. Highlights Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis – DCF Analysis – P/E Analysis – Peer Valuation – CrispIdea Forecast Relative […]

February 15, 2021

Becton, Dickinson and Company (BDX) – COVID 19 Testing sales created positive impact on company performance

BDX’s expanding innovation pipeline is focused on healthcare’s shifting trends leveraging BD’s core strengths. The company is applying smart devices, robotics & analytics/AI to improve care processes and lower costs. Highlights Valuation – Enterprise Value – CrispIdea Forecast – Economic Value Added Analysis – P/E Analysis – Peer Valuation – CrispIdea Forecast Relative to Consensus […]

January 19, 2021

Chemed Corporation (CHE – Q3FY20) – Quarter performance was led by growth in Roto- Rooter and VITAS.

Chemed Corporation, operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – Company Overview – Q3FY20 Results – Overview – Segment […]

January 13, 2021

Medtronic plc (MDT -Q2-FY21) – Recovery in business led to improvement in quarter performance.

MDT has increased their focus on allocating capital to their best opportunities, and they are supplementing this with an increased cadence of tuck in acquisitions. The company announced seven acquisitions in 2020 with total value of more than $1.6bn. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

January 6, 2021

Becton, Dickinson and Co. (BDX – Q4FY20 & FY20) – Quarter performance positively affected by COVID-19 testing revenue.

BD Life Sciences segment, revenues for the quarter of $1.488bn increased 31.2% over the prior-year period. The segment’s results were driven by strong sales related to COVID-19 diagnostic testing solutions in the Diagnostic Systems unit on the BD VeritorTM and BD MaxTM platforms. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet […]

December 16, 2020

Boston Scientific Corporation (BSX – Q3FY20) – Acquisition of BTG plc contributed towards revenue growth.

BSX initiated the U.S. launch of the SpaceOAR Vue™ Hydrogel, a next-generation hydrogel spacer that is designed to reduce the side effects of prostate radiation therapy, while providing clinicians with the added ability to view the spacer using computerized tomography (CT) scans instead of magnetic resonance imaging (MRI). Executive Summary Financial Statements – Income Statement […]

November 12, 2020

Abbott Laboratories (ABT- Q3FY20) – Medical Devices and Diagnostics contributed towards revenue growth.

Abbott revenues increased by 9.6% to $8.85bn in Q3FY20. The increase was driven by an increase in the Diagnostics segment as a result of demand for Abbott’s portfolio of COVID 19 diagnostics tests on its lab based immunoassay and molecular diagnostics systems and point of care rapid testing platforms. Sales growth in Medical Devices and […]

November 6, 2020

Thermo Fisher Scientific’s Inc (TMO – Q3FY20) – Exceptional performance in the quarter due to growth in Life Sciences Solutions segment.

The company launched innovative Thermo Scientific products across businesses, highlighted by two Selectris imaging filters for cryo-electron microscopes that accelerate research in structural analysis of proteins, and the POROS Oligo (dT)25 Affinity Resin to advance mRNA-based therapies and vaccines. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow – […]

October 31, 2020

Medtronic plc (MDT-Q1FY21) – Product approvals and launches expected to lead the growth of the company.

Medtronic plc | is experiencing the benefit of new product launches as pipeline kicks in across the company. They had over 130 regulatory approvals this calendar year in the US, Europe, Japan, and China. Procedure volumes began to recover this quarter in multiple markets around the world, and drove market share gains in a number […]

October 9, 2020

Becton, Dickinson and Co. (BDX – Q3FY20) – Quarter performance affected by COVID-19 pandemic.

Becton, Dickinson and Co launched four new products in the quarter and remain on track to deliver robust innovation pipeline for the year. It launched an upgrade to the BD FACS Melody to expand from 2-way sorting to 4-way sorting, enabling customers to capture more cell types. Executive Summary Financial Statements – Income Statement and […]

September 30, 2020

Boston Scientific Corporation (BSX – Q2FY20) – Positive impact of Vertiflex acquisition on revenue.

Boston Scientific Corporation| will be launching LUX-Dx implantable cardiac monitor, which will offer a seamless patient interface and back-end monitoring. It will have the ability to be programmed remotely and have event detection settings adjusted without an in person visit. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet – Cash Flow […]

September 22, 2020

Thermo Fisher Scientific’s Inc (TMO – Q2FY20) – Quarter performance positively affected by increase in demand.

Life Sciences Solutions Segment revenue increased by 52.16% to $2.6bn in Q2FY20 due to increased sales of genetic sciences products, driven primarily by tests for diagnosis of COVID-19. Sales grew, to a lesser extent, due to higher demand for biosciences and bio-production products. Executive Summary Financial Statements – Income Statement and Forecast – Balance Sheet […]

August 26, 2020

Abbott Laboratories (ABT Q2FY20) – FreeStyle Libre and COVID 19 test kits were the performance drivers.

Abbott announced it has received approval from the U.S. Food and Drug Administration (FDA) for the use of the company’s Patient Controller app on compatible personal Apple smartphone devices. At Abbott, this approval allows patients living with neurological conditions, including chronic pain or movement disorders, the ability to manage therapy directly from their personal smartphone. […]

August 18, 2020

Medtronic plc (MDT Q4FY20 & FY20) – MDT’s performance was affected due to COVID 19 pandemic.

Medtronic plc, the global leader in medical technology, introduced the MiniMed™ Mio™ Advance infusion set to all Medtronic insulin pump customers in the United States. The MiniMed Mio Advance infusion set is the newest addition to the MiniMed™ portfolio of infusion sets and gives people using insulin pumps an optimal user experience with fewer steps1. […]

July 31, 2020

Becton, Dickinson and Co. (BDX – Q2FY20) – Strong growth across business segments led to progress in Q2FY20.

Becton, Dickinson and Company completed the acquisition of Straub Medical, which will further expands the company’s portfolio with a proven device with that’s approved with dual indications for arterial atherectomy and thrombectomy in the U.S. It has solid existing sales in Europe and China. The company is leveraging their strong existing channel and expertise in […]

June 8, 2020

Boston Scientific Corporation (BSX – Q1FY20) – Lower performance expected in coming quarters due to COVID-19.

Boston Scientific announced positive 12-month results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-generation WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device for patients with nonvalvular atrial fibrillation (NVAF). Presented as a late-breaking clinical trial at HRS 2020 SCIENCE, the study evaluated performance of the WATCHMAN FLX device as […]

June 2, 2020

Abbott Laboratories (ABT – Q1FY20) – Abbott’s near-term performance impacted by COVID-19.

Abbott recently launched three diagnostics tests for COVID 19, including molecular tests on its ID NOW™ rapid point of care platform and m 2000 RealTime lab based platform, and a serology blood test for the detection of the antibody, IgG, on its lab based immunoassay platforms. Organic sales growth in the quarter was led by strong […]

October 17, 2019

Medtronic plc – Double-digit growth in emerging market led to growth in FY19

Medtronic’s revenues increased by 2% to $30.56bn for FY19, which was below our guidance of $31.15bn for FY19. Revenues in Q4FY19 increased by $2mn to $8.14bn which adjusts for a $289mn negative impact from foreign currency No. of Pages – 44 Contents Executive Summary Financial Statements –Income Statement and Forecast –Balance Sheet –Cash Flow –Q4FY19 […]

June 19, 2019

Thermo Fisher Scientific (TMO) – Acquisition of Brammer Bio will boost growth for TMO

TMO completed the acquisition of Brammer Bio, a leader in viral vector manufacturing for gene and cell therapies, for ~$1.7bn in cash. Brammer will become part of TMO’s Pharma Services business within its Laboratory Products and Services Segment. This acquisition will boost growth for the company and therefore, we expect 4% growth in revenues in […]

June 11, 2019

Abbott Laboratories (ABT) – Double-digit growth in growth drivers – FreeStyle Libre, MitraClip and Alinity

Abbott delivered strong Q1FY19 performance with 2% growth in revenues on reported basis and 7.1% growth in revenues on an organic basis. The growth was due to double-digit growth in FreeStyle Libre, MitraClip and Alinity. The adjusted EPS grew by 6.8% to $0.63 in Q1FY19 Number of pages – 41 Content: Executive Summary………………………………………………………..1 Financial Statements […]